Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Cardiovasc Nurs. 2019 Jan-Feb;34(1):E1–E7. doi: 10.1097/JCN.0000000000000536

Table 4.

General linear model results for factors associated with Framingham RHI without plasminogen activator inhibitor-1

Predictor b SE 95% CI p-value
Sex, male −.305 .083 −.471, −.139 <.001
Employment, full-time .126 .071 −.014, .26 .077
Calcium channel blocker usage, yes −.148 .070 −.287, −.010 .036
Beta-blocker usage, yes −.007 .076 −.144, .159 .925
Body mass index −.014 .006 −.026, −.001 .037
Diastolic blood pressure .006 .004 −.002, .014 .098
Total cholesterol to high-density lipoprotein cholesterol ratio −.048 .042 −.131, .035 .256
Apnea hypoxia index −.002 .004 −.010, .005 .562

Abbreviations: SE, standard error; CI, confidence interval; RHI, reactive hyperemia index

R squared = .263